Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025

Page 14 of 14

1. The Oncology Institute (NASDAQ:TOI)

Number of Hedge Fund Holders In Q3 2024: 8

The Oncology Institute (NASDAQ:TOI) is an oncology group that provides cancer care services in the U.S.

The stock has surged so far in 2025 due to solid financials. Q3 2024 revenue grew 21.8% year-over-year to $99.9 million. This was driven by an 80% surge in Dispensary revenue from oral cancer drugs.

It also achieved its first quarterly cash surplus in 2024. Cash reserves thus increased by $1 million and SG&A expenses have been reduced by 6% year-over-year.

The company signed 13 new capitation contracts in 2024 and this included agreements that contributed over $50 million in annual revenue.

It has also deployed AI-driven treatment algorithms.

The consensus price target of $2.5 implies 169.4% upside.

TOI stock is up 203.4% year-to-date.

While we acknowledge the potential of TOI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TOI but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: Why These 15 Industrial Stocks Are Skyrocketing So Far In 2025 and Why These 15 Oil & Gas Stocks Are Skyrocketing So Far In 2025

Disclosure: None. This article was originally published at Insider Monkey.

Page 14 of 14